117 related articles for article (PubMed ID: 34226219)
1. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.
Kjellberg A; Douglas J; Pawlik MT; Kraus M; Oscarsson N; Zheng X; Bergman P; Frånberg O; Kowalski JH; Nyren SP; Silvanius M; Skold M; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
BMJ Open; 2021 Jul; 11(7):e046738. PubMed ID: 34226219
[TBL] [Abstract][Full Text] [Related]
2. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
4. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO).
Kjellberg A; Douglas J; Hassler A; Al-Ezerjawi S; Boström E; Abdel-Halim L; Liwenborg L; Hetting E; Jonasdottir Njåstad AD; Kowalski J; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510965
[TBL] [Abstract][Full Text] [Related]
6. The outcomes of COVID-19 measures in a hyperbaric oxygen therapy centre during the pandemic.
Ozgok-Kangal K; Zaman T; Koc B
Int Marit Health; 2021; 72(3):228-236. PubMed ID: 34604994
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol.
Falandry C; Malapert A; Roche M; Subtil F; Berthiller J; Boin C; Dubreuil J; Ravot C; Bitker L; Abraham P; Collange V; Balança B; Goutte S; Guichon C; Gadea E; Argaud L; Dayde D; Jallades L; Lepape A; Pialat JB; Friggeri A; Thiollière F;
BMJ Open; 2021 Jul; 11(7):e044449. PubMed ID: 34230013
[TBL] [Abstract][Full Text] [Related]
8. Virtual reality for relatives of ICU patients to improve psychological sequelae: study protocol for a multicentre, randomised controlled trial.
Vlake JH; van Bommel J; Wils EJ; Korevaar T; Hellemons ME; Klijn E; Schut AF; Labout JA; Van Bavel MP; van Mol MM; Gommers D; van Genderen ME
BMJ Open; 2021 Sep; 11(9):e049704. PubMed ID: 34588250
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and outcome analysis of COVID-19-associated pneumothorax: multicentre retrospective critical care experience from Qatar.
Akram J; Yousaf Z; Alabbas Y; Almoyaaf MIA; Ibrahim ASS; Kharma N
BMJ Open; 2022 Feb; 12(2):e053398. PubMed ID: 35190427
[TBL] [Abstract][Full Text] [Related]
10. Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
Reignier J; Le Gouge A; Lascarrou JB; Annane D; Argaud L; Hourmant Y; Asfar P; Badie J; Nay MA; Botoc NV; Brisard L; Bui HN; Chatellier D; Chauvelot L; Combes A; Cracco C; Darmon M; Das V; Debarre M; Delbove A; Devaquet J; Voicu S; Aissaoui-Balanant N; Dumont LM; Oziel J; Gontier O; Groyer S; Guidet B; Jaber S; Lambiotte F; Leroy C; Letocart P; Madeux B; Maizel J; Martinet O; Martino F; Mercier E; Mira JP; Nseir S; Picard W; Piton G; Plantefeve G; Quenot JP; Renault A; Guérin L; Richecoeur J; Rigaud JP; Schneider F; Silva D; Sirodot M; Souweine B; Reizine F; Tamion F; Terzi N; Thévenin D; Thiéry G; Thieulot-Rolin N; Timsit JF; Tinturier F; Tirot P; Vanderlinden T; Vinatier I; Vinsonneau C; Maugars D; Giraudeau B
BMJ Open; 2021 May; 11(5):e045041. PubMed ID: 33980526
[TBL] [Abstract][Full Text] [Related]
11. TELE-critical Care verSus usual Care On ICU PErformance (TELESCOPE): protocol for a cluster-randomised clinical trial on adult general ICUs in Brazil.
Noritomi DT; Ranzani OT; Ferraz LJR; Dos Santos MC; Cordioli E; Albaladejo R; Serpa Neto A; Correa TD; Berwanger O; de Morais LC; Schettino G; Cavalcanti AB; Rosa RG; Biondi RS; Salluh JI; Azevedo LCP; Pereira AJ;
BMJ Open; 2021 Jun; 11(6):e042302. PubMed ID: 34155070
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
[TBL] [Abstract][Full Text] [Related]
13. Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
Voiriot G; Fartoukh M; Durand-Zaleski I; Berard L; Rousseau A; Armand-Lefevre L; Verdet C; Argaud L; Klouche K; Megarbane B; Patrier J; Richard JC; Reignier J; Schwebel C; Souweine B; Tandjaoui-Lambiotte Y; Simon T; Timsit JF;
BMJ Open; 2021 Aug; 11(8):e048187. PubMed ID: 34408046
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
Dhar R; Kirkpatrick J; Gilbert L; Khanna A; Modi MM; Chawla RK; Dalal S; Maturu VN; Stern M; Keppler OT; Djukanovic R; Gadola SD
PLoS One; 2023; 18(1):e0280745. PubMed ID: 36689456
[TBL] [Abstract][Full Text] [Related]
15. Inhaled Nitric Oxide ReDuce postoperatIve pulmoNAry complicaTions in patiEnts with recent COVID-19 infection (INORDINATE): protocol for a randomised controlled trial.
Zheng Z; Wang L; Wang S; Fan Q; Zhang H; Luo G; Gao B; Yang X; Zhao B; Wang X; Dong H; Nie H; Lei C
BMJ Open; 2024 Mar; 14(3):e077572. PubMed ID: 38485487
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial.
Cannellotto M; Duarte M; Keller G; Larrea R; Cunto E; Chediack V; Mansur M; Brito DM; García E; Di Salvo HE; Verdini F; Domínguez C; Jorda-Vargas L; Roberti J; Di Girolamo G; Estrada E
Emerg Med J; 2022 Feb; 39(2):88-93. PubMed ID: 34907003
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.
Kjellberg A; Hassler A; Boström E; El Gharbi S; Al-Ezerjawi S; Kowalski J; Rodriguez-Wallberg KA; Bruchfeld J; Ståhlberg M; Nygren-Bonnier M; Runold M; Lindholm P
BMC Infect Dis; 2023 Jan; 23(1):33. PubMed ID: 36670365
[TBL] [Abstract][Full Text] [Related]
18. Dutch multicentre, prospective follow-up, cohort study comparing the neurological and neuropsychological sequelae of hospitalised non-ICU- and ICU-treated COVID-19 survivors: a study protocol.
Klinkhammer S; Horn J; Visser-Meilij JMA; Verwijk E; Duits A; Slooter AJC; van Heugten CM;
BMJ Open; 2021 Oct; 11(10):e054901. PubMed ID: 34620676
[TBL] [Abstract][Full Text] [Related]
19. Validating a clinical laboratory parameter-based deisolation algorithm for patients with COVID-19 in the intensive care unit using viability PCR: the CoLaIC multicentre cohort study protocol.
Schoenmakers T; van Bussel BCT; Gorissen SHM; van Loo IHM; van Rosmalen F; Verboeket-van de Venne WPHG; Wolffs PFG; van Mook WNKA; Leers MPG; ;
BMJ Open; 2023 Feb; 13(2):e069455. PubMed ID: 36854586
[TBL] [Abstract][Full Text] [Related]
20. I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.
Files DC; Matthay MA; Calfee CS; Aggarwal NR; Asare AL; Beitler JR; Berger PA; Burnham EL; Cimino G; Coleman MH; Crippa A; Discacciati A; Gandotra S; Gibbs KW; Henderson PT; Ittner CAG; Jauregui A; Khan KT; Koff JL; Lang J; LaRose M; Levitt J; Lu R; McKeehan JD; Meyer NJ; Russell DW; Thomas KW; Eklund M; Esserman LJ; Liu KD; ;
BMJ Open; 2022 Jun; 12(6):e060664. PubMed ID: 35667714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
